Granite Investment Partners’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-604,045
Closed -$10.8M 265
2025
Q2
$10.8M Sell
604,045
-49,286
-8% -$859K 0.52% 74
2025
Q1
$11.6M Sell
653,331
-33,396
-5% -$758K 0.59% 66
2024
Q4
$20.5M Buy
+686,727
New +$14.5M 0.88% 29
2023
Q1
Sell
-33,164
Closed -$2.43M 273
2022
Q4
$2.43M Buy
33,164
+14,768
+80% +$1.11M 0.1% 186
2022
Q3
$1.4M Buy
+18,396
New +$1.43M 0.06% 206
2021
Q3
Sell
-935
Closed -$207K 284
2021
Q2
$207K Buy
+935
New +$182K 0.01% 265
2021
Q1
Sell
-29,692
Closed -$5.14M 285
2020
Q4
$5.14M Sell
29,692
-1,521
-5% -$208K 0.18% 127
2020
Q3
$3.47M Buy
31,213
+431
+1% +$34.5K 0.15% 134
2020
Q2
$1.82M Buy
30,782
+825
+3% +$54.3K 0.09% 186
2020
Q1
$2.02M Sell
29,957
-231,358
-89% -$18.3M 0.13% 158
2019
Q4
$22M Buy
261,315
+14,480
+6% +$1.17M 1.04% 25
2019
Q3
$18.5M Sell
246,835
-164,824
-40% -$13.2M 0.95% 34
2019
Q2
$26M Buy
411,659
+15,501
+4% +$785K 1.4% 8
2019
Q1
$19.1M Buy
396,158
+63,491
+19% +$3.06M 1.08% 19
2018
Q4
$11.1M Sell
332,667
-216,661
-39% -$7.92M 0.81% 52
2018
Q3
$28.8M Buy
549,328
+22,273
+4% +$887K 1.66% 3
2018
Q2
$16.5M Buy
+527,055
New +$14.7M 1.04% 19

Other funds holding NVCR

Granite Investment Partners's NVCR Position: Q3 2025 in Review

Granite Investment Partners sold out of NovoCure (NVCR) in Q3 2025, closing a stake of 604,045 shares — an estimated $10.8M sold.

Granite Investment Partners first reported a position in NVCR in Q2 2018 and held it in 17 quarters. The position peaked at $28.8M in Q3 2018. 245 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Granite Investment Partners reported no remaining NovoCure position as of Q3 2025 after selling out during the quarter.
  • Granite Investment Partners sold 604,045 NovoCure shares in Q3 2025, an estimated $10.8M.
  • Granite Investment Partners first reported a position in NovoCure in Q2 2018 and held it in 17 quarters.
  • Granite Investment Partners's NovoCure position peaked at $28.8M in Q3 2018.
  • 245 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Granite Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.